Athenex, Inc.

Athenex, Inc. (formerly Kinex Pharmaceuticals, Inc., the "Company") is a specialty pharmaceutical company focused on the development and commercialisation of next generation therapies for cancer and immunomodulatory diseases.  The company has utilised the proprietary platform technologies Mimetica^TM, Opal^TM and Orascovery^TM to discover new compounds and to build a pipeline of drug candidates with unique mechanisms that address unmet medical needs with large market potential.

For more information on the Company, please click here.